首页> 外国专利> METHOD OF DETERMINING THE RISK OF DEVELOPING BREAST CANCER BY DETECTING THE EXPRESSION LEVELS OF MICRORNAS (MIRNAS)

METHOD OF DETERMINING THE RISK OF DEVELOPING BREAST CANCER BY DETECTING THE EXPRESSION LEVELS OF MICRORNAS (MIRNAS)

机译:通过检测微小RNA(miRNA)的表达水平来确定发展为乳腺癌的风险的方法

摘要

The present disclosure describes methods of determining the risk of developing breast cancer in a subject or determining whether a subject suffers from breast cancer. The methods can comprise detecting the expression level of microRNAs (miRNAs) hsa-miR-186-5p (SEQ ID NO: 77) and/or hsa-miR-409-3p (SEQ ID NO: 178) in a bodily fluid sample obtained from the subject and determining whether it is upregulated or downregulated as compared to a control, wherein the upregulation of hsa-miR-186-5p (SEQ ID NO: 77) and/or downregulation of hsa-miR-409-3p (SEQ ID NO: 178) indicates that the subject has breast cancer or is at risk of developing breast cancers. Also encompassed are methods of prognosis or diagnosis of breast cancer by detecting expression levels of combinations of miRNAs and using a score based on a panel of miRNA markers.
机译:本公开描述了确定受试者中患乳腺癌的风险或确定受试者是否患有乳腺癌的方法。该方法可以包括检测所获得的体液样品中的microRNA(miRNA)hsa-miR-186-5p(SEQ ID NO:77)和/或hsa-miR-409-3p(SEQ ID NO:178)的表达水平与受试者相比,确定其是否被上调或下调,其中hsa-miR-186-5p(SEQ ID NO:77)的上调和/或hsa-miR-409-3p(SEQ ID NO:9) NO:178)表示受试者患有乳腺癌或有患乳腺癌的风险。还包括通过检测miRNA的组合的表达水平并使用基于一组miRNA标志物的评分来预后或诊断乳腺癌的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号